Invests in publicly listed European healthcare companies across innovative, specialty, and generic pharmaceuticals, medical technology, diagnostics, life science tools, pharmaceutical distribution, and specialized healthcare services, including selected acquisition-led healthcare platforms. The focus is on businesses with clear strategic positioning, strong positions in selected markets, attractive opportunities for organic growth and reinvestment, and the capacity to create long-term value through innovation, operational excellence, and disciplined capital allocation.
European Healthcare Growth Analytics →
Explore the long-term trends, business models, and structural growth drivers shaping Bolna’s European Healthcare Growth portfolio.
Updated 2026-10-30